As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bristol-Myers Squibb: IMC Chicago LLC, Nomura Holdings Inc., Readystate Asset Management LP, Parallax Volatility Advisers L.P., BlueCrest Capital Management Ltd, Caas Capital Management LP, CMT Capital Markets Trading GmbH, Cubist Systematic Strategies LLC, Nomura Holdings Inc., Cresset Asset Management LLC, PEAK6 Investments LLC, DCF Advisers LLC, Eisler Capital UK Ltd., Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, Baader Bank Aktiengesellschaft, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., M&T Bank Corp, XR Securities LLC, Wolverine Asset Management LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.